95251 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Histamine H3 receptor agents, preparation and therapeutic uses
#2102NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#2103PHTHALAZINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#2104Imidazole-5-carboxylic acid derivatives, the preparation method therefor and the uses thereof
#2105Benzimidazole derivatives and their use for modulating the GABAreceptor complex
#2106Benzimidazole derivatives and their use for modulating the GABAreceptor complex
#2107Compounds and Uses Thereof
#2108Five-membered heterocycles useful as serine protease inhibitors
#2109Dual-acting imidazole antihypertensive agents
#2110Process for the preparation of candesartan cilexetil
#2111Compounds and Uses Thereof
#2112Substituted pyrazinone derivatives for use in MCH-1 mediated diseases
#2113Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
#2114Thyroid hormone analogs
#2115Dual-acting benzoimidazole antihypertensive agents
#2116Process for the preparation of sartan derivatives and intermediates useful in such process
#2117Quinoxaline-containing compounds and polymers thereof
#2118Sesquihydrate hydrochloride salt of irbesartan
#2119Modulators of Chemokine Receptor Activity
#2120Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
#2121Inhibitors of thapsigargin-induced cell death
#2122NEW COMPOUNDS 835
#2123Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
#2124Process for Preparing an Angiotensin II Receptor Antagonist
#2125PHTHALAZINONE DERIVATIVES
#2126Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
#2127N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
#2128Dual-acting antihypertensive agents
#2129Inhibitors of poly(ADP-ribose)polymerase
#2130Aromatic amine derivative and organic electroluminescence device employing the same
#2131Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)
#2132Certain chemical entities, compositions, and methods
#2133PHTHALAZINONE DERIVATIVES
#2134Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds
#2135Compounds for alzheimer's disease
#2136Triazole compounds and uses related thereto
#2137MODULATION OF PROTEIN FUNCTIONALITIES
#2138Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
#2139Process for the synthesis of solifenacin
#21401-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis
#2141Cyclopropyl amine derivatives
#2142Melanocortin receptor-specific compounds
#2143Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#2144Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
#2145Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
#2146Process for the Synthesis of Tetrazoles
#21472-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists
#2148Modified azole compounds as antifungal and antibacterial agents
#21492-Propene-1-Ones As Hsp 70 Inducers
#2150Cannabinoid Receptor Modulators
#2151Phthalazinone derivatives
#2152Angiotensin II receptor antagonists
#21535-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
#2154Crystal of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid and process for producing the same
#2155Modified Azole Compounds As Antifungal and Antibacterial Agents
#2156New Compounds 617
#2157Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
#2158Compounds
#2159Vapor deposited electro-optic films self-assembled through hydrogen bonding
#2160Pyrazole compounds and uses related thereto
#2161Urea derivative, medicinal composition containing the same, and medicinal use of these
#2162INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE
#2163Compounds 620
#2164Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis
#2165PREPARATION AND UTILITY OF SUBSTITUTED PHENYLTETRAZOLES
#2166Certain chemical entities, compositions, and methods
#2167Anti-inflammatory medicaments
#2168Synthesis of triazole compounds that modulate HSP90 activity
#2169Substituted imidazoles
#2170PHENYLTETRAZOLE COMPOUNDS
#2171Substituted imidazoles
#2172Dimeric small molecule potentiators of apoptosis
#2173Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
#2174Substituted quinazolinones for treating neurological conditions
#2175Phthalazine compounds and methods of use
#2176N-substituted-azacyclylamines as histamine-3 antagonists
#2177Anthracene derivative, and light-emitting element, light-emitting device, and electronic appliance using the same
#2178Process for the Production of Candesartan
#2179Enzyme modulators and treatments
#2180Processes for the synthesis of 5-phenyl-1-trityl-1H-tetrazole
#2181Amorphous and Crystalline Forms of Losartan Potassium and Process For Their Preparation
#2182Hydrates of alkaline-earth salts of irbesartan and the preparation thereof
#2183Triazole compounds that modulate HSP90 activity
#2184Preparation of losartan 5-carboxylic acid and use thereof
#2185Quinoxaline derivative, and light-emitting device, electronic device using the quinoxaline derivative
#21861H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
#21872,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION
#2188Pyrrole derivatives and their methods of use
#2189Anti-inflammatory medicaments
#2190Metal complex compound and organic electroluminescent element using the same
#2191Quinazoline derivatives as angiogenesis inhibitors
#2192Dimeric pyrrolidine amide-containing small molecule apoptosis promoters
#2193Compounds which potentiate AMPA receptor and uses thereof in medicine
#2194Pyrrolidine Derivatives as Histamine Receptors Ligands
#21951-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
#2196Modified azole compounds as antifungal and antibacterial agents
#2197Electroluminescent Device
#2198Compounds that modulate HSP90 activity and methods for identifying same
#2199S1P receptor modulating compounds and use thereof
#2200Cyclopropyl amine derivatives
#2201Benzimidazole derivatives
#2202Metalloprotease inhibitors
#2203NEW COMPOUNDS I/418
#2204S1P receptor modulating compounds and use thereof
#2205Diaminotriazoles useful as inhibitors of protein kinases
#2206Imidazole Compound
#2207Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#2208Triazole compounds that modulate HSP90 activity
#2209Substituted indoles
#2210Biaryl Derivatives
#2211Substituted phenyl methanone derivatives
#2212Methods for treating hepatitis C
#2213Pharmaceutical Formulation
#2214Phosphodiesterase 10 inhibitors
#2215Acrylonitrile derivatives for inflammation and immune-related uses
#2216Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine
#2217Compounds
#2218Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists
#22192,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
#2220Phosphodiesterase 10 inhibitors
#2221SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS
#2222Benzimidazole derivatives, their production and use
#2223Process for the Preparation of Losartan Potassium Form I
#2224Pyrrole derivatives with angiotensin II antagonist activity
#22252,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
#2226Process for preparing nitrooxy esters, nitrooxy thioesters nitrooxy carbonates and nitrooxy thiocarbinates, intermediates useful in said process and preparation thereof
#2227Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
#2228Compounds for the treatment of proliferative disorders
#2229Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
#2230Arylalkylamine compound and process for preparing the same
#2231N-substituted-azacyclylamines as histamine-3 antagonists
#2232Multi-cycle cinnamide derivatives
#2233Synthesis of irbesartan
#2234Histamine H3 receptor agents, preparation and therapeutic uses
#2235TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H3 RECEPTOR
#2236Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
#2237MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
#2238Anti-inflammatory medicaments
#2239Material for organic electroluminescence device and organic electroluminescence device utilizing the same
#2240Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
#2241Compounds and compositions for treating obesity
#2242Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#22431H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
#2244Method for preparing irbesartan and intermediates thereof
#2245SUBSTITUTED PYRIMIDINONES
#22464-Carbox pyrazole derivatives useful as anti-viral agents
#2247Substituted imidazoles
#2248Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
#2249Triazole compounds that modulate HSP90 activity
#2250Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
#2251Imidazoyl-benzamide anti-cancer agents
#2252Compounds and uses thereof
#2253Compounds and uses thereof
#2254Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
#2255PHARMACEUTICALLY ACTIVE PYRROLIDINE ESTER DERIVATIVES
#2256N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
#2257Heterocycle-substituted 3-alkyl azetidine derivatives
#2258Pyrimidinone compounds useful as kinase inhibitors
#2259Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
#2260Pyrazole Derivatives
#22615-lipdxygenase-activating protein (FLAP) inhibitors
#2262Oxindole compounds and their uses as therapeutic agents
#2263Process for preparation of Irbesartan
#2264Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
#2265PROCESS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTIC COMPOUNDS
#2266Phthalazinone derivatives
#2267Imidazole compounds that modulate HSP90 activity
#2268Pyrrole compounds for the treatment of prostaglandine mediated diseases
#2269Stable micronized candesartan cilexetil and methods for preparing thereof
#2270Novel mercaptobenzimidazole substituted benzotriazole UV absorber and process for preparation thereof
#2271Cyclobutyl amine derivatives
#2272Enzyme modulators and treatments
#2273Androgen modulators
#2274Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
#2275Heterocyclic aspartyl protease inhibitors
#2276Imidazole compounds for the treatment of neurological disorders
#2277Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
#2278Mitotic kinesin inhibitors
#2279Aryl nitrogen-containing bicyclic compounds and methods of use
#2280Process for the preparation of tetrazole derivatives from organo aluminium azides
#22812-aminopyrimidine derivatives and their medical use
#2282Compositions of novel opioid compounds and method of use thereof
#2283Phenyl pyrrolidine ether tachykinin receptor antagonists
#2284Anti-inflammatory medicaments
#2285Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use
#2286Thyroid hormone analogs
#2287Novel compounds useful for bradykinin B1 receptor antagonism
#22882-Amino-quinazolin-5-ones
#2289Large substituent, non-phenolic opioids
#22902-Aminophenyl-4-phenylpyrimidines as kinase inhibitors
#2291Contrast agent
#2292Imidazole derivatives, preparation method thereof and organic electronic device using the same
#2293Fused pyramidine derivative and use thereof
#2294N-substituted piperazines
#2295Matrix metalloproteinase inhibitors
#2296Substituted 3-alkyl and 3-alkenyl azetidine derivatives
#2297Method of removing the triphenylmethane protecting group
#2298Melanocortin receptor-specific piperazine and keto-piperazine compounds
#2299Melanocortin receptor-specific piperazine compounds with diamine groups
#2300L-Threonine derivatives of high therapeutic index
#2301Benzimidazole and imidazopyridine derivatives and use thereof as a medicament
#2302Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
#2303Anti-cancer agents and uses thereof
#2304Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them
#2305Substituted pyrazoles
#2306N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
#2307Preparation of candesartan cilexetil
#2308Androgen modulators
#23093-aminopyrrolidine derivatives as modulators of chemokine receptors
#2310N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#2311Amorphous form of losartan potassium
#2312Process for preparing losartan potassium with improved flowability
#2313Substituted piperazines as CB1 antagonists
#2314Compounds with high therapeutic index
#2315Losartan potassium crystalline form alpha
#2316Method of treatment or prophylaxis
#2317Heteroaryl-substituted alkyne compounds and method of use
#2318Process for the preparation of angiotensin receptor blockers and intermediates thereof
#2319Protein kinase modulators and methods of use
#23202-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
#2321Crystal and process for producing the same
#2322Novel compounds
#2323Factor Xa compounds
#2324Preparation of crude candesartan cilexetil
#2325Bicyclic-substituted amines as histamine-3 receptor ligands
#2326Organic compound and organic electrolumiscent device
#2327Methods for treating hepatitis C
#2328Biaryl substituted pyrazoles as sodium channel blockers
#23293-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors of factor Xa
#2330Aminoalkylphenyl indolone derivatives
#2331Agent for preventing or treating portal hypertension
#23322-amido pyrazines for inflammation and immune related uses
#2333Triazole compounds that modulate Hsp90 activity
#2334N-heterocyclyl phenyl-substituted cyclic ketoenols
#2335Ureas as factor Xa inhibitors
#2336Aromatic amine derivative and organic electroluminescence device employing the same
#2337Phthalazinone derivatives
#2338Substituted 1,4-benzodiazepines and uses thereof
#2339Glutamate receptor antagonists
#2340Substituted n-aryl nitrogen heterocycles
#2341Hetereoaryl nitrile derivatives
#2342Pyrrolines
#2343Synthesis of irbesartan
#2344Synthesis of irbesartan
#2345Intermediates for the synthesis of irbesartan
#2346Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one
#2347Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
#2348Quinoline and quinoxaline compounds
#2349Heterocycle substituted carboxylic acids
#2350Benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
#2351N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library
#2352Small molecule modulators of cytokine activity
#2353Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
#2354Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
#2355Heterocyclic aspartyl protease inhibitors
#23562-Thiopyrimidinones as therapeutic agents
#2357Bradykinin-B1 antagonists, process for their preparation and their use as medicaments
#2358Pyrazole derivatives as cannabinoid receptor antagonists
#2359Imidazopyridinyl-benzamide anti-cancer agents
#2360Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
#2361Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
#2362Anilino-pyrimidine analogs
#2363Preparation of olmesartan medoxomil
#2364Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
#2365Cytokine inhibitors
#2366Method for preparing irbesartan and intermediates thereof
#23672-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
#2368Indazoles
#2369Pyrazole analogs acting on cannabinoid receptors
#2370Uracils having a herbicidal activity
#2371Triazole derivative
#2372Substituted triazoles as sodium channel blockers
#2373Process for preparing losartan
#2374CCK-1 receptor modulators
#2375Histamine-3 agonists and antagonists
#2376Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
#2377Alpha,beta-unsaturated esters and acids by stereoselective dehydration
#2378Substituted heterocycles for the treatment of diabetes and other diseases
#2379Anti-inflammatory medicaments
#2380Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase
#2381Five-membered heterocycles useful as serine protease inhibitors
#2382Sleep inducing compounds and methods relating thereto
#2383Pyrazole compounds and uses related thereto
#2384Acrylonitrile derivatives for inflammation and immune-related uses
#23856-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
#2386Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4
#23871h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
#2388Ophthalmic compositions for treating ocular hypertension
#2389Candesartan cilexetil polymorphs
#2390Preparation of candesartan cilexetil in high purity
#2391Material for organic electroluminescence devices and organic electroluminescence device using the material
#2392Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#2393Benzyl(idene)-lactam derivatives
#2394Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
#23958-(biaryl)quinoline PDE4 inhibitors
#2396Glutamate receptor antagonists
#2397Inhibitors of Akt activity
#2398Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
#2399Melanin concentrating hormone receptor antagonist
#2400Dimeric small molecule potentiators of apoptosis